4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-023072
Chief Medical Officer sold 10,000 shares at an average $66.57 ($665,747)
- Chief Medical Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Chief Medical Officer | 2019-04-01 | Option exercise | +10,000 | $35.16 | $351,600 | 17,238 | D |
| Bowden Christopher Chief Medical Officer | 2019-04-01 | Sale | −5,854 | $66.03 | $386,540 | 11,384 | D |
| Bowden Christopher Chief Medical Officer | 2019-04-01 | Sale | −2,546 | $66.85 | $170,200 | 8,838 | D |
| Bowden Christopher Chief Medical Officer | 2019-04-01 | Sale | −1,500 | $68.09 | $102,135 | 7,338 | D |
| Bowden Christopher Chief Medical Officer | 2019-04-01 | Sale | −100 | $68.72 | $6,872 | 7,238 | D |
| Derivatives | |||||||
| Bowden Christopher Chief Medical Officer | 2019-04-01 | Option exercise · Stock option (right to buy) | −10,000 | 71,000 | D | ||
| Open-market sales · 10,000 sh · avg $66.57 · $665,747 | |||||||
Loading xslF345X03/doc4.xml…